TME PHARMA NV (ALTME.PA) Stock Income Statement
Europe - EPA:ALTME - NL0015000YE1 - Common Stock
0.0962 EUR
+0 (+0.52%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | 0.00 | 1.00K | 0.00 | 0.00 | |||
| Operating Expenses | 4.28M | 4.82M | 12.01M | 13.46M | 5.82M | |||
| Research and Development | 2.30M | 2.65M | 8.15M | 10.66M | 4.02M | |||
| Selling, General, and Administrative Expenses | 2.00M | 2.19M | 3.88M | 2.88M | 1.88M | |||
| Operating Income | -4.28M | -4.82M | -12.01M | -13.46M | -5.82M | |||
| Interest Income/Expense | 5.00K | -4.00K | -44.00K | -1.28M | -4.92M | |||
| Other Income/Expense | -469.00K | -1.11M | -3.09M | 270.00K | 300.00K | |||
| Non Recurring Items | -981.00K | -804.00K | 18.00K | 10.00K | 40.00K | |||
| Income Before Taxes | -5.72M | -6.73M | -15.13M | -14.45M | -10.41M | |||
| Income Tax | 0.00 | 2.00K | 7.00K | 0.00 | 0.00 | |||
| Net Income | -5.72M | -6.74M | -15.13M | -14.45M | -10.41M | |||
| EBITDA | -4.20M | -4.68M | -11.92M | -13.39M | -5.76M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.16 | -1.34 | -12.86 | -21.90 | -32.53 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in EUR